ANTIBODIES TO HUMAN IFN IN JPL PATIENTS TREATED WITH HUMAN IFN
ANTIBODIES TO HUMAN IFN IN JPL PATIENTS TREATED WITH HUMAN IFN
批准号:
3748188
负责人:
J BEKISZ
金额:
$0.0万
依托单位:
--
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
adolescence (12-20) antigen antibody reaction biological response modifiers cutaneous papilloma enzyme linked immunosorbent assay human therapy evaluation human tissue hyperplasia immunotherapy interferon alpha larynx disorder larynx neoplasms neoplasm /cancer immunotherapy neutralizing antibody recombinant proteins
中文摘要
135例人白细胞α治疗患者血清标本分析
干扰素(胡干扰素(Le)(纽约血液中心,纽约州梅尔维尔))为
幼年性喉乳头状瘤(J.L.P.)进行了现场测试
上述α干扰素的中和抗体。
11个样本被发现含有阿尔法中和抗体
来自纽约不列颠哥伦比亚州的干扰素。其中10种含有中和作用
抗人白细胞α干扰素抗体(干扰素
科学,新泽西州新不伦瑞克)九株含有中和抗体
重组α干扰素(内含子A,先灵葆雅,凯尼尔沃思,
新泽西州)。没有一种样品能与Alferon或Intron结合
在酶联免疫吸附试验中。然而,Six确实与Wellferon(Burroughs)绑定
韦尔科姆,英国贝肯汉姆)这是一种天然的淋巴母细胞干扰素。
由于我们在实验室中使用Wellferon作为
开始的材料,我们有兴趣确定是否有
阳性样品与我们纯化的成分的结合。我们发现了一个
三个样品与含有以下物质的洗脱液的低水平结合
其中两个物种。尽管上述物种的数量
是一个限制因素,我们正在进行分析,这将
显示存在的抗体是否与其中一种或两种发生反应
组件。
英文摘要
Serum samples from 135 patients treated with human leukocyte alpha
interferon (Hu IFN (Le) (New York Blood Center, Melville, N.Y. ) for
Juvenile Laryngeal Papillomatosis (J.L.P.) were tested for the presence
of neutralizing antibodies to the above mentioned alpha interferon.
Eleven samples were found to contain neutralizing antibodies to alpha
interferon from the N.Y.B.C. Ten of these contained neutralizing
antibodies to Human leukocyte alpha interferon (Alferon; Interferon
Sciences, New Brunswick, N.J.) and nine contained neutralizing antibodies
to recombinant alpha interferon (Intron A, Schering-Plough, Kenilworth,
N.J.). None of the samples were seen to bind to either Alferon or Intron
in ELISA assays. Six, however, did bind to Wellferon (Burroughs
Wellcome, Beckenham, U.K.) which is a natural lymphoblastoid interferon.
Since we purify IFN-a components in our laboratory using Wellferon as
starting material, we were interested to determine if there was any
binding of the positive samples to our purified components. We found a
low level of binding by three of the samples to an eluate which contains
two of the species. Although the quantity of the aforementioned species
is a limiting factor, we are in the process of running assays which will
show if the antibody present reacts with one or both of these
components.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRYPTIC DIGESTION OF INTERFERON COMPONENTS
-
批准号:3792473
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J BEKISZ
-
依托单位:--
ANTIBODIES TO HUMAN IFN IN JLP PATIENTS TREATED WITH HUMAN IFN
-
批准号:3792459
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J BEKISZ
-
依托单位:--
ANTIBODIES TO HUMAN IFN IN J.L.P. PATIENTS TREATED WITH HUMAN IFN
-
批准号:3804736
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:J BEKISZ
-
依托单位:--
海外基金